[Convulsive status epilepticus in infants. Semiologic, etiologic and prognostic aspects].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to O Dulac.
Explore the source record for details and available documents.
80 epileptic children were treated with sodium valproate as a monotherapy for a mean duration of 15 months. The fits stopped in 50% and diminished in 27.5% of cases. The treatment was particularly efficient in primary generalized epilepsies (cessation in 77%, reduction in 18% of cases), in the photosensitive epilepsies, and in children with a normal mental development. Reducing a multiple treatment to valproate monotherapy resulted in behavioral improvement in 10 of 11 cases and in a reduction or even a discontinuation of the fits. Drowsiness, insomnia, hair loss, gastrointestinal disturbances and weight gaining were the most important side effects. Evaluations of the plasmatic levels in relation to daily doses allow to advise a mean daily dose of 20-30 mg/kg depending on the child's age.
Report of one case of agranulocytosis occurring in a 23 months old child, during treatment of visceral leishmaniasis by antimony.